外源性一氧化氮在口腔疾病治疗中的研究进展
本综述系统梳理了外源性一氧化氮(NO)在牙体牙髓、牙周、种植、黏膜、正畸及口腔癌等疾病中的治疗机制与递送平台。NO通过cGMP、S-亚硝基化、sGC-cGMP-PKG及JNK/MAPK等通路发挥抗菌、抗炎、促修复及诱导肿瘤细胞凋亡作用。多数证据来自临床前研究,剂量精准性与递送特异性仍待解决。
要点
- 外源性NO具有广谱抗菌、抗炎、促组织再生及潜在抗肿瘤的多靶点特性。
- NO递送平台包括纳米载体、水凝胶、种植体涂层和微针,覆盖多种口腔疾病。
- 现有证据多源于临床前研究,剂量准确性和递送特异性是临床转化的主要挑战。
核心结论
- 外源性NO凭借多靶点特性,有望作为口腔疾病治疗的辅助策略,但临床转化仍需解决剂量与递送问题。
研究设计与样本
- 本文为综述,检索范围未在原文中明确报告。
主要发现
- NOS失调及内源性NO生成受损参与多种口腔疾病的病理过程。
- 外源性NO通过调节cGMP通路、介导S-亚硝基化、激活sGC-cGMP-PKG通路及调控JNK/MAPK通路发挥作用。
- 上述机制赋予外源性NO抗菌效力、免疫调节、增强牙周与牙髓组织修复及诱导口腔癌细胞凋亡的能力。
- 纳米载体、水凝胶、种植体涂层和微针等NO递送平台在牙周炎、种植体周围炎、龋病、牙髓根尖周病、口腔溃疡、正畸牙移动及口腔癌管理中显示疗效。
关键数值与推荐
- 原文未报告具体数值、阈值或推荐条款。
临床怎么用
- 外源性NO可作为牙周炎、种植体周围炎、龋病、牙髓根尖周病、口腔溃疡、正畸牙移动及口腔癌的辅助治疗策略。
- 临床选择NO递送平台时需关注其在不同口腔疾病中的应用证据,目前多来自临床前研究。
局限性
- 目前多数证据来自临床前研究。
- 剂量准确性和递送特异性仍存在重大挑战。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Nitric oxide (NO), a gaseous signaling molecule, is increasingly recognized for its central role in the pathophysiology of dental and oral diseases. Dysregulation of nitric oxide synthase (NOS) and consequent impairment of endogenous NO production have been implicated in a range of oral conditions. Accordingly, exogenous NO therapy has garnered significant interest due to its broad-spectrum antibacterial, potent anti-inflammatory, tissue-regenerative, and potential antitumor effects. This review provides a comprehensive overview of therapeutic advances in exogenous NO for dental and oral diseases, focusing on underlying mechanisms, such as modulation of the cyclic di-guanosine monophosphate pathway, mediation of S-nitrosylation, activation of the soluble guanylate cyclase-cyclic guanosine monophosphate-protein kinase G pathway, and regulation of the c-Jun N-terminal kinase/mitogen-activated protein kinase pathway. Collectively, these mechanisms confer antimicrobial efficacy, immunomodulation, enhanced periodontal and pulpal tissue repair, and apoptosis induction in oral cancer cells. Various NO delivery platforms, including nanocarriers, hydrogels, implant coatings, and microneedles, are reviewed for their efficacy and application in managing periodontitis, peri-implantitis, dental caries, endodontic and periapical diseases, oral ulcers, orthodontic tooth movement, and oral cancer. Although most of the current evidence is derived from preclinical studies and substantial challenges remain with respect to dosing accuracy and delivery specificity, the unique multitarget properties of exogenous NO highlight its considerable promise as an adjunctive strategy in dental medicine. This review seeks to provide a comprehensive overview that not only advances fundamental understanding of exogenous NO but also promotes its clinical translation for improved management of dental and oral diseases.
引用
- Zhang Q, Lu L, Liu C, et al. Exogenous Nitric Oxide in the Treatment of Dental and Oral Diseases. J Dent Res. 2026. PMID: 41837758. doi:10.1177/00220345261429478
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。